• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种计算简单的中央监测程序,有效地应用于已知存在欺诈行为的实证试验数据。

A computationally simple central monitoring procedure, effectively applied to empirical trial data with known fraud.

作者信息

van den Bor Rutger M, Vaessen Petrus W J, Oosterman Bas J, Zuithoff Nicolaas P A, Grobbee Diederick E, Roes Kit C B

机构信息

Julius Clinical Ltd., Broederplein 41-43, 3703 CD Zeist, The Netherlands; Julius Center for Health Sciences and Primary Care, UMC Utrecht, P.O. Box 85500, 3508 GA Utrecht, The Netherlands.

Julius Clinical Ltd., Broederplein 41-43, 3703 CD Zeist, The Netherlands.

出版信息

J Clin Epidemiol. 2017 Jul;87:59-69. doi: 10.1016/j.jclinepi.2017.03.018. Epub 2017 Apr 12.

DOI:10.1016/j.jclinepi.2017.03.018
PMID:28412468
Abstract

OBJECTIVES

Central monitoring of multicenter clinical trials becomes an ever more feasible quality assurance tool, in particular for the detection of data fabrication. More widespread application, across both industry sponsored as well as academic clinical trials, requires central monitoring methodologies that are both effective and relatively simple in implementation.

STUDY DESIGN AND SETTING

We describe a computationally simple fraud detection procedure intended to be applied repeatedly and (semi-)automatically to accumulating baseline data and to detect data fabrication in multicenter trials as early as possible. The procedure is based on anticipated characteristics of fabricated data. It consists of seven analyses, each of which flags approximately 10% of the centers. Centers that are flagged three or more times are considered "potentially fraudulent" and require additional investigation. The procedure is illustrated using empirical trial data with known fraud.

RESULTS

In the illustration data, the fraudulent center is detected in most repeated applications to the accumulating trial data, while keeping the proportion of false-positive results at sufficiently low levels.

CONCLUSION

The proposed procedure is computationally simple and appears to be effective in detecting center-level data fabrication. However, assessment of the procedure on independent trial data sets with known data fabrication is required.

摘要

目的

多中心临床试验的中央监测成为一种越来越可行的质量保证工具,特别是用于检测数据造假。在行业资助的临床试验和学术临床试验中更广泛地应用,需要有效且实施相对简单的中央监测方法。

研究设计与设置

我们描述了一种计算简单的欺诈检测程序,旨在反复(半)自动应用于累积的基线数据,并尽早检测多中心试验中的数据造假。该程序基于伪造数据的预期特征。它由七项分析组成,每项分析标记约10%的中心。被标记三次或更多次的中心被视为“潜在欺诈”,需要进一步调查。使用已知欺诈的经验性试验数据对该程序进行了说明。

结果

在示例数据中,在对累积试验数据的大多数重复应用中都检测到了欺诈中心,同时将假阳性结果的比例保持在足够低的水平。

结论

所提出的程序计算简单,似乎在检测中心层面的数据造假方面有效。然而,需要在具有已知数据造假的独立试验数据集上对该程序进行评估。

相似文献

1
A computationally simple central monitoring procedure, effectively applied to empirical trial data with known fraud.一种计算简单的中央监测程序,有效地应用于已知存在欺诈行为的实证试验数据。
J Clin Epidemiol. 2017 Jul;87:59-69. doi: 10.1016/j.jclinepi.2017.03.018. Epub 2017 Apr 12.
2
Central statistical monitoring: detecting fraud in clinical trials.中心统计监测:发现临床试验中的欺诈行为。
Clin Trials. 2013 Apr;10(2):225-35. doi: 10.1177/1740774512469312. Epub 2013 Jan 2.
3
Strategies for dealing with fraud in clinical trials.临床试验中应对欺诈行为的策略。
Int J Clin Oncol. 2016 Feb;21(1):22-7. doi: 10.1007/s10147-015-0876-6. Epub 2015 Jul 21.
4
An Appraisal of the Carlisle-Stouffer-Fisher Method for Assessing Study Data Integrity and Fraud.卡尔利斯勒-斯托弗-费希尔法评估研究数据完整性和欺诈的评估。
Anesth Analg. 2017 Oct;125(4):1381-1385. doi: 10.1213/ANE.0000000000002415.
5
Research misconduct and data fraud in clinical trials: prevalence and causal factors.临床试验中的研究不端行为和数据欺诈:发生率及因果因素
Int J Clin Oncol. 2016 Feb;21(1):15-21. doi: 10.1007/s10147-015-0887-3. Epub 2015 Aug 20.
6
Clinician-trialist rounds: 19. Faux pas or fraud? Identifying centers that have fabricated their data in your multi-center trial.
Clin Trials. 2014 Feb;11(1):128-30. doi: 10.1177/1740774513503524. Epub 2013 Oct 3.
7
The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials.生物统计学在临床试验中欺诈行为的预防、检测和处理中的作用。
Stat Med. 1999 Dec 30;18(24):3435-51. doi: 10.1002/(sici)1097-0258(19991230)18:24<3435::aid-sim365>3.0.co;2-o.
8
Detection of atypical data in multicenter clinical trials using unsupervised statistical monitoring.使用无监督统计监测在多中心临床试验中检测非典型数据。
Clin Trials. 2019 Oct;16(5):512-522. doi: 10.1177/1740774519862564. Epub 2019 Jul 23.
9
Integrity of scientific data: transparency of clinical trial data.科学数据的完整性:临床试验数据的透明度。
Therapie. 2007 May-Jun;62(3):203-9, 211-6. doi: 10.2515/therapie:2007043. Epub 2007 Sep 6.
10
A statistical approach to central monitoring of data quality in clinical trials.一种临床试验数据质量中心监测的统计方法。
Clin Trials. 2012 Dec;9(6):705-13. doi: 10.1177/1740774512447898. Epub 2012 Jun 8.

引用本文的文献

1
Central statistical monitoring in clinical trial management: A scoping review.临床试验管理中的中央统计监测:一项范围综述。
Clin Trials. 2025 Jun;22(3):342-351. doi: 10.1177/17407745241304059. Epub 2025 Jan 2.
2
Assessing the Integrity of Clinical Trials Included in Evidence Syntheses.评估纳入证据综合的临床试验的完整性。
Int J Environ Res Public Health. 2023 Jun 15;20(12):6138. doi: 10.3390/ijerph20126138.
3
Consistency of covid-19 trial preprints with published reports and impact for decision making: retrospective review.
新冠病毒19临床试验预印本与已发表报告的一致性及其对决策的影响:回顾性审查
BMJ Med. 2022 Oct 3;1(1):e000309. doi: 10.1136/bmjmed-2022-000309. eCollection 2022.
4
Evidence and risk indicators of non-random sampling in clinical trials in implant dentistry: A systematic appraisal.种植体牙科临床试验中非随机抽样的证据和风险指标:系统评价。
J Clin Periodontol. 2022 Feb;49(2):144-152. doi: 10.1111/jcpe.13571. Epub 2021 Nov 19.
5
Dynamic methods for ongoing assessment of site-level risk in risk-based monitoring of clinical trials: A scoping review.动态方法在临床试验基于风险监测中的现场级风险持续评估中的应用:范围综述。
Clin Trials. 2021 Apr;18(2):245-259. doi: 10.1177/1740774520976561. Epub 2021 Feb 20.
6
Triggered or routine site monitoring visits for randomised controlled trials: results of TEMPER, a prospective, matched-pair study.随机对照试验的触发或常规现场监测访问:前瞻性、配对研究 TEMPER 的结果。
Clin Trials. 2018 Dec;15(6):600-609. doi: 10.1177/1740774518793379. Epub 2018 Aug 22.
7
Imbalance values for baseline covariates in randomized controlled trials: a last resort for the use of values? A pro and contra debate.随机对照试验中基线协变量的失衡值:使用这些值的最后手段?正反观点辩论。
Clin Epidemiol. 2018 May 8;10:531-535. doi: 10.2147/CLEP.S161508. eCollection 2018.